• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用机器学习和分子对接研究对1,7-萘啶类似物的PIP4K2A抑制活性进行建模。

Modelling PIP4K2A inhibitory activity of 1,7-naphthyridine analogues using machine learning and molecular docking studies.

作者信息

Ibrahim Muktar Musa, Uzairu Adamu, Ibrahim Muhammad Tukur, Umar Abdullahi Bello

机构信息

Department of Chemistry, Faculty of Physical Sciences, Ahmadu Bello University P. M. B 1045 Zaria Nigeria

出版信息

RSC Adv. 2023 Jan 24;13(6):3402-3415. doi: 10.1039/d2ra07382j.

DOI:10.1039/d2ra07382j
PMID:36756602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9871732/
Abstract

PIP4K2A is a type II lipid kinase that catalyzed the rate-limiting step of the conversion of phosphatidylinositol-5-phosphate (PI5P) into phosphatidylinositol 4,5-bisphosphate (PI4,5P2). PIP4K2A has been intricately linked to the inhibition of various types of tumors reactive oxygen species-mediated apoptosis, making it an important therapeutic target. In the quest of finding biologically active substances with efficient PIP4K2A inhibitory activity, machine learning algorithms were used to investigate the quantitative relationship between structures and inhibitory activities of 1,7-naphthyridine analogues. Three machine learning algorithms (MLR, ANN, and SVM) were used to develop QSAR models that can effectively predict the PIP4K2A inhibitory activity of a library of 1,7-naphthyridine analogues. The cascaded feature selection method was performed by sequential application of GFA and MP5 algorithms to identify a molecular descriptor subset that can best describe the PIP4K2A inhibitory activity of 1,7-naphthyridine analogues. PIP4K2A inhibitory activities predicted by the ML models were strongly correlated with the experimental values. The QSAR Modelling indicates that the best-performing ML model was SVM with the RBF kernel function. The SVM model performed very well in predicting PIP4K2A inhibitory activity of the 1,7-naphthyridine analogues with RTR and QEX values of 0.9845 and 0.8793 respectively. To further gain more structural insight into the origin of PIP4K2A inhibitory activity of 1,7-naphthyridine analogues, molecular docking studies were performed. The results indicate that five compounds; 15, 25, 13, 09, and 28 were found to have a high binding affinity with the receptor molecules. Hydrogen bonding, pi-pi interaction, and pi-cation interactions were found to modulate the binding interaction of the inhibitors. Although the SVM gives essentially a black-box model which cannot be readily interpreted, using SVM in tandem with MLR and ANN provides a unique perspective in building robust QSAR predictive models. The superior predictive performance of the ML models and the explanatory power of MLR models were combined to provide a unique insight into the structure-activity relationship of 1,7-naphthyridine inhibitors. This is relevant in that it provides information that can be invaluable as guidelines for the design of novel PIP4K2A inhibitors.

摘要

PIP4K2A是一种II型脂质激酶,催化磷脂酰肌醇-5-磷酸(PI5P)转化为磷脂酰肌醇4,5-二磷酸(PI4,5P2)的限速步骤。PIP4K2A与抑制各种类型肿瘤的活性氧介导的细胞凋亡密切相关,使其成为一个重要的治疗靶点。为了寻找具有高效PIP4K2A抑制活性的生物活性物质,使用机器学习算法研究了1,7-萘啶类似物的结构与抑制活性之间的定量关系。使用三种机器学习算法(MLR、ANN和SVM)开发了QSAR模型,该模型可以有效预测1,7-萘啶类似物文库的PIP4K2A抑制活性。通过依次应用GFA和MP5算法进行级联特征选择方法,以识别能够最好地描述1,7-萘啶类似物的PIP4K2A抑制活性的分子描述符子集。ML模型预测的PIP4K2A抑制活性与实验值高度相关。QSAR建模表明,性能最佳的ML模型是具有RBF核函数的SVM。SVM模型在预测1,7-萘啶类似物的PIP4K2A抑制活性方面表现非常出色,RTR和QEX值分别为0.9845和0.8793。为了进一步深入了解1,7-萘啶类似物的PIP4K2A抑制活性的结构起源,进行了分子对接研究。结果表明,发现五种化合物(15、25、13、09和28)与受体分子具有高结合亲和力。发现氢键、π-π相互作用和π-阳离子相互作用调节抑制剂的结合相互作用。尽管SVM本质上给出了一个难以解释的黑箱模型,但将SVM与MLR和ANN串联使用为构建强大的QSAR预测模型提供了独特的视角。ML模型的卓越预测性能和MLR模型的解释能力相结合,为1,7-萘啶抑制剂的构效关系提供了独特的见解。这很重要,因为它提供了作为新型PIP4K2A抑制剂设计指南可能非常宝贵的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/47851ff81f3b/d2ra07382j-f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/17d633f9a969/d2ra07382j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/6a2149f62a9b/d2ra07382j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/5b14f5c2e875/d2ra07382j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/ce819d3fcb16/d2ra07382j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/fb0d31e8a2b3/d2ra07382j-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/f0cf5bcff30f/d2ra07382j-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/479e1145bdc3/d2ra07382j-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/617bd3c8e90d/d2ra07382j-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/5323766371fe/d2ra07382j-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/65d4d071c7d1/d2ra07382j-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/784e2fee9c3f/d2ra07382j-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/b93a5b89b3a3/d2ra07382j-f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/ea193ebb2217/d2ra07382j-f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/73693dbfc318/d2ra07382j-f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/47851ff81f3b/d2ra07382j-f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/17d633f9a969/d2ra07382j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/6a2149f62a9b/d2ra07382j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/5b14f5c2e875/d2ra07382j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/ce819d3fcb16/d2ra07382j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/fb0d31e8a2b3/d2ra07382j-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/f0cf5bcff30f/d2ra07382j-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/479e1145bdc3/d2ra07382j-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/617bd3c8e90d/d2ra07382j-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/5323766371fe/d2ra07382j-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/65d4d071c7d1/d2ra07382j-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/784e2fee9c3f/d2ra07382j-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/b93a5b89b3a3/d2ra07382j-f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/ea193ebb2217/d2ra07382j-f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/73693dbfc318/d2ra07382j-f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d650/9871732/47851ff81f3b/d2ra07382j-f15.jpg

相似文献

1
Modelling PIP4K2A inhibitory activity of 1,7-naphthyridine analogues using machine learning and molecular docking studies.利用机器学习和分子对接研究对1,7-萘啶类似物的PIP4K2A抑制活性进行建模。
RSC Adv. 2023 Jan 24;13(6):3402-3415. doi: 10.1039/d2ra07382j.
2
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A.激酶PIP4K2A的强效且高度选择性的基于1,7-萘啶的抑制剂BAY-091和BAY-297的发现与表征
J Med Chem. 2021 Nov 11;64(21):15883-15911. doi: 10.1021/acs.jmedchem.1c01245. Epub 2021 Oct 26.
3
A simple and robust model to predict the inhibitory activity of α-glucosidase inhibitors through combined QSAR modeling and molecular docking techniques.通过组合 QSAR 建模和分子对接技术,建立一个简单而强大的模型来预测α-葡萄糖苷酶抑制剂的抑制活性。
Mol Divers. 2021 Aug;25(3):1811-1825. doi: 10.1007/s11030-020-10164-5. Epub 2021 Feb 9.
4
Exploring QSARs of the interaction of flavonoids with GABA (A) receptor using MLR, ANN and SVM techniques.采用多元线性回归(MLR)、人工神经网络(ANN)和支持向量机(SVM)技术探索黄酮类化合物与 GABA(A) 受体相互作用的定量构效关系(QSARs)。
J Enzyme Inhib Med Chem. 2014 Oct;29(5):670-6. doi: 10.3109/14756366.2013.839557. Epub 2013 Oct 9.
5
Do we need different machine learning algorithms for QSAR modeling? A comprehensive assessment of 16 machine learning algorithms on 14 QSAR data sets.我们是否需要不同的机器学习算法来进行定量构效关系建模?对 16 种机器学习算法在 14 个定量构效关系数据集上的综合评估。
Brief Bioinform. 2021 Jul 20;22(4). doi: 10.1093/bib/bbaa321.
6
QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.使用对接衍生分子描述符对HIV-1蛋白酶抑制活性进行定量构效关系预测。
J Theor Biol. 2015 Mar 21;369:13-22. doi: 10.1016/j.jtbi.2015.01.008. Epub 2015 Jan 16.
7
Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer's disease.用于预测乙酰胆碱酯酶和 BACE1 双重抑制剂治疗阿尔茨海默病活性的机器学习模型。
Mol Divers. 2022 Jun;26(3):1501-1517. doi: 10.1007/s11030-021-10282-8. Epub 2021 Jul 29.
8
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.使用逐步多元线性回归(MLR)、因子分析多元线性回归(FA-MLR)、偏最小二乘法(PLS)、广义因子分析(GFA)、广义偏最小二乘法(G/PLS)和人工神经网络(ANN)技术对结构多样的化合物的细胞色素3A4抑制活性进行比较化学计量学建模。
Eur J Med Chem. 2009 Jul;44(7):2913-22. doi: 10.1016/j.ejmech.2008.12.004. Epub 2008 Dec 16.
9
In Silico Prediction of O⁶-Methylguanine-DNA Methyltransferase Inhibitory Potency of Base Analogs with QSAR and Machine Learning Methods.基于 QSAR 和机器学习方法的碱基类似物对 O⁶-甲基鸟嘌呤-DNA 甲基转移酶抑制活性的计算预测。
Molecules. 2018 Nov 6;23(11):2892. doi: 10.3390/molecules23112892.
10
Discovering the Active Ingredients of Medicine and Food Homologous Substances for Inhibiting the Cyclooxygenase-2 Metabolic Pathway by Machine Learning Algorithms.利用机器学习算法发现抑制环氧化酶-2代谢途径的药食同源物质的有效成分。
Molecules. 2023 Sep 23;28(19):6782. doi: 10.3390/molecules28196782.

引用本文的文献

1
Activity prediction, structure-based drug design, molecular docking, and pharmacokinetic studies of 1,4-dihydropyridines derivatives as α-amylase inhibitors.1,4-二氢吡啶衍生物作为α-淀粉酶抑制剂的活性预测、基于结构的药物设计、分子对接及药代动力学研究
J Taibah Univ Med Sci. 2023 Dec 22;19(2):270-286. doi: 10.1016/j.jtumed.2023.12.003. eCollection 2024 Apr.

本文引用的文献

1
Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.通过二维定量构效关系(2D-QSAR)、三维定量构效关系(3D-QSAR)、分子对接和药物代谢及毒性预测(ADMET),对一些1,3-噻嗪衍生物作为靶向H1N1神经氨酸酶的抗流感抑制剂进行计算建模研究。
Beni Suef Univ J Basic Appl Sci. 2022;11(1):104. doi: 10.1186/s43088-022-00280-6. Epub 2022 Aug 19.
2
The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib.PI3K 相关血管畸形的发生发生在血管生成过程中,并可被 AKT 抑制剂 miransertib 所预防。
EMBO Mol Med. 2022 Jul 7;14(7):e15619. doi: 10.15252/emmm.202115619. Epub 2022 Jun 13.
3
Malarial PI4K inhibitor induced diaphragmatic hernias in rat: Potential link with mammalian kinase inhibition.疟原虫 PI4K 抑制剂诱导大鼠膈疝:与哺乳动物激酶抑制的潜在联系。
Birth Defects Res. 2022 Jun;114(10):487-498. doi: 10.1002/bdr2.2012. Epub 2022 Apr 13.
4
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?PI3K/Akt/mTOR信号通路及其在癌症治疗中的作用:我们有进展吗?
Front Oncol. 2022 Mar 24;12:819128. doi: 10.3389/fonc.2022.819128. eCollection 2022.
5
American Cancer Society nutrition and physical activity guideline for cancer survivors.美国癌症协会癌症幸存者营养与身体活动指南。
CA Cancer J Clin. 2022 May;72(3):230-262. doi: 10.3322/caac.21719. Epub 2022 Mar 16.
6
Metabolic tricks of cancer cells.癌细胞的代谢技巧。
Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188705. doi: 10.1016/j.bbcan.2022.188705. Epub 2022 Mar 8.
7
Cancer statistics for African American/Black People 2022.2022 年非裔美国人/黑人癌症统计数据。
CA Cancer J Clin. 2022 May;72(3):202-229. doi: 10.3322/caac.21718. Epub 2022 Feb 10.
8
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A.激酶PIP4K2A的强效且高度选择性的基于1,7-萘啶的抑制剂BAY-091和BAY-297的发现与表征
J Med Chem. 2021 Nov 11;64(21):15883-15911. doi: 10.1021/acs.jmedchem.1c01245. Epub 2021 Oct 26.
9
PIP4Ks impact on PI3K, FOXP3, and UHRF1 signaling and modulate human regulatory T cell proliferation and immunosuppressive activity.PIP4Ks 影响 PI3K、FOXP3 和 UHRF1 信号转导,并调节人调节性 T 细胞的增殖和免疫抑制活性。
Proc Natl Acad Sci U S A. 2021 Aug 3;118(31). doi: 10.1073/pnas.2010053118.
10
Emerging cell biological functions of phosphatidylinositol 5 phosphate 4 kinase.磷脂酰肌醇 5 磷酸 4 激酶的新兴细胞生物学功能。
Curr Opin Cell Biol. 2021 Aug;71:15-20. doi: 10.1016/j.ceb.2021.01.012. Epub 2021 Mar 4.